MoonLake Immunotherapeutics (MLTX) stock
Close on Nov 13, 2026Market cap $1.06BP/E –Yield –
Earnings
MoonLake Immunotherapeutics's quarterly results as reported in its earnings releases, with the company's own outlook. Hover a number to see the sentence it came from.
Quarterly results
Revenue and earnings per share from each of MoonLake Immunotherapeutics's earnings releases, newest first
| Quarter | Reported | Revenue | YoY | EPS | Source |
|---|---|---|---|---|---|
| Q4 FY2026ended Dec 31, 2026 | Feb 22, 2027Expected | – | – | – | – |
| Q3 FY2026ended Sep 30, 2026 | Nov 4, 2026before the open | – | – | -$0.93 | Release |
| Q2 FY2026ended Jun 30, 2026 | Aug 10, 2026before the open | – | – | -$0.84 | Release |
| Q1 FY2026ended Mar 31, 2026 | May 11, 2026before the open | – | – | – | Release |
| Q4 FY2025ended Dec 31, 2025 | Feb 23, 2026before the open | – | – | – | Release |
| Q3 FY2025ended Sep 30, 2025 | Nov 5, 2025before the open | – | – | -$1.10 | Release |
| Q2 FY2025ended Jun 30, 2025 | Aug 5, 2025before the open | – | – | – | Release |
| Q1 FY2025ended Mar 31, 2025 | May 12, 2025during market hours | – | – | – | Release |
| Q4 FY2024ended Dec 31, 2024 | Feb 26, 2025before the open | – | – | – | Release |
| Q3 FY2024ended Sep 30, 2024 | Nov 7, 2024before the open | – | – | – | Release |
| Q2 FY2024ended Jun 30, 2024 | Aug 7, 2024before the open | – | – | -$0.39 | Release |
| Q1 FY2024ended Mar 31, 2024 | May 7, 2024before the open | – | – | -$0.22 | Release |
| Q4 FY2023ended Dec 31, 2023 | Feb 29, 2024before the open | – | – | -$0.12 | Release |
| Q3 FY2023ended Sep 30, 2023 | Nov 14, 2023before the open | – | – | -$0.18 | Release |
| Q2 FY2023ended Jun 30, 2023 | Aug 10, 2023before the open | – | – | -$0.23 | Release |
| Q4 FY2022ended Dec 31, 2022 | Mar 20, 2023before the open | – | – | -$0.31 | Release |
Figures as first announced; later restatements appear under Financials. Expected dates are estimated from the company's past reporting pattern.
Guidance
MoonLake Immunotherapeutics has not given guidance in its releases
Many companies give their outlook only on the conference call or not at all. When MoonLake Immunotherapeutics puts a forecast in an earnings release, it is listed here with the exact sentence.
Press releases
Releases MoonLake Immunotherapeutics filed with the SEC as exhibits to Form 8-K or 6-K
- Results
- Results
- Update
- Update
- Results
- Results
- News
- Results
- News
- Results
- Results
- Update
- Results
- Results
- Results
See a number that looks wrong?